Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models

Systemic chemotherapy using two-drug platinum-based regimens for the treatment of advanced stage non-small cell lung cancer (NSCLC) has largely reached a plateau of effectiveness. Accordingly, efforts to improve survival and quality of life outcomes have more recently focused on the use of molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Proia, David A., Sang, Jim, He, Suqin, Smith, Donald L., Sequeira, Manuel, Zhang, Chaohua, Liu, Yuan, Ye, Shuxia, Zhou, Dan, Blackman, Ronald K., Foley, Kevin P., Koya, Keizo, Wada, Yumiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Preclinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484281/
https://www.ncbi.nlm.nih.gov/pubmed/22227828
http://dx.doi.org/10.1007/s10637-011-9790-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484281/
https://www.ncbi.nlm.nih.gov/pubmed/22227828
http://dx.doi.org/10.1007/s10637-011-9790-6

Ejemplares similares